Coronado VG, Xu L, Basavaraju SV, McGuire LC, Wald MM, Faul MD, et al. Surveillance for traumatic brain injury-related deaths–United States, 1997–2007. MMWR Surveill Summ. 2011;60:1–32.

PubMed  Google Scholar 

Zhao JB, Zhang Y, Li GZ, Su XF, Hang CH. Activation of JAK2/STAT pathway in cerebral cortex after experimental traumatic brain injury of rats. Neurosci Lett. 2011;498:147–52.

Article  CAS  PubMed  Google Scholar 

Bryan MA, Rowhani-Rahbar A, Comstock RD, Rivara F. Sports- and recreation-related concussions in US youth. Pediatrics. 2016;138:e20154635.

Article  PubMed  Google Scholar 

McKinlay A, Grace RC, Horwood LJ, Fergusson DM, Ridder EM, MacFarlane MR. Prevalence of traumatic brain injury among children, adolescents and young adults: prospective evidence from a birth cohort. Brain Inj. 2008;22:175–81.

Article  CAS  PubMed  Google Scholar 

Ryu WH, Feinstein A, Colantonio A, Streiner DL, Dawson DR. Early identification and incidence of mild TBI in Ontario. Can J Neurol Sci. 2009;36:429–35.

Article  PubMed  Google Scholar 

Barlow KM. Postconcussion syndrome: a review. J Child Neurol. 2016;31:57–67.

Article  PubMed  Google Scholar 

Barlow KM, Crawford S, Stevenson A, Sandhu SS, Belanger F, Dewey D. Epidemiology of postconcussion syndrome in pediatric mild traumatic brain injury. Pediatrics. 2010;126:e374–81.

Article  PubMed  Google Scholar 

Ojo JO, Mouzon BC, Crawford F. Repetitive head trauma, chronic traumatic encephalopathy and tau: challenges in translating from mice to men. Exp Neurol. 2016;275:389–404.

Article  PubMed  Google Scholar 

Donat CK, Scott G, Gentleman SM, Sastre M. Microglial activation in traumatic brain injury. Front Aging Neurosci. 2017;9:208.

Article  PubMed  PubMed Central  Google Scholar 

Erblich B, Zhu L, Etgen AM, Dobrenis K, Pollard JW. Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS ONE. 2011;6:e26317.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014;82:380–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Das M, Mayilsamy K, Mohapatra SS, Mohapatra S. Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects. Rev Neurosci. 2019;30:839–55.

Article  PubMed  Google Scholar 

Kassis I, Vaknin-Dembinsky A, Karussis D. Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection. Curr Stem Cell Res Ther. 2011;6:63–8.

Article  CAS  PubMed  Google Scholar 

Liang X, Ding Y, Zhang Y, Tse HF, Lian Q. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 2014;23:1045–59.

Article  PubMed  Google Scholar 

Lim H, Park SH, Kim SW, Cho KO. Therapeutic potential of human turbinate-derived mesenchymal stem cells in experimental acute ischemic stroke. Int Neurourol J. 2018;22:S131–8.

Article  PubMed  PubMed Central  Google Scholar 

Lim JY, Lee JE, Park SA, Park SI, Yon JM, Park JA, et al. Protective effect of human-neural-crest-derived nasal turbinate stem cells against amyloid-β neurotoxicity through inhibition of osteopontin in a human cerebral organoid model of Alzheimer’s disease. Cells. 2022;11:1029.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yun BG, Lee SH, Jeon JH, Kim SW, Jung CK, Park G, et al. Accelerated bone regeneration via three-dimensional cell-printed constructs containing human nasal turbinate-derived stem cells as a clinically applicable therapy. ACS Biomater Sci Eng. 2019;5:6171–85.

Article  CAS  PubMed  Google Scholar 

Lim JY, In Park S, Park SA, Jeon JH, Jung HY, Yon JM, et al. Potential application of human neural crest-derived nasal turbinate stem cells for the treatment of neuropathology and impaired cognition in models of Alzheimer’s disease. Stem Cell Res Ther. 2021;12:402.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yi HJ, Lee JE, Lee DH, Kim YI, Cho CB, Kim IS, et al. The role of NLRP3 in traumatic brain injury and its regulation by pioglitazone. J Neurosurg. 2019:1–9.

Loane DJ, Kumar A. Microglia in the TBI brain: the good, the bad, and the dysregulated. Exp Neurol. 2016;275(Pt 3):316–27.

Article  CAS  PubMed  Google Scholar 

Bohnert S, Seiffert A, Trella S, Bohnert M, Distel L, Ondruschka B, et al. TMEM119 as a specific marker of microglia reaction in traumatic brain injury in postmortem examination. Int J Legal Med. 2020;134:2167–76.

Article  PubMed  PubMed Central  Google Scholar 

Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, Stewart W. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain. 2013;136:28–42.

Article  PubMed  PubMed Central  Google Scholar 

Gottlieb A, Toledano-Furman N, Prabhakara KS, Kumar A, Caplan HW, Bedi S, et al. Time dependent analysis of rat microglial surface markers in traumatic brain injury reveals dynamics of distinct cell subpopulations. Sci Rep. 2022;12:6289.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian C, Wang X, Wang X, Wang L, Wang X, Wu S, et al. Autologous bone marrow mesenchymal stem cell therapy in the subacute stage of traumatic brain injury by lumbar puncture. Exp Clin Transplant. 2013;11:176–81.

Article  PubMed  Google Scholar 

Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330:841–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin WN, Shi SX, Li Z, Li M, Wood K, Gonzales RJ, et al. Depletion of microglia exacerbates postischemic inflammation and brain injury. J Cereb Blood Flow Metab. 2017;37:2224–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726–36.

Article  CAS  PubMed  Google Scholar 

Lee JK, Jin HK, Endo S, Schuchman EH, Carter JE, Bae JS. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer’s disease mice by modulation of immune responses. Stem Cells. 2010;28:329–43.

Article  CAS  PubMed  Google Scholar 

Sheikh AM, Nagai A, Wakabayashi K, Narantuya D, Kobayashi S, Yamaguchi S, et al. Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5. Neurobiol Dis. 2011;41:717–24.

Article  CAS  PubMed  Google Scholar 

Danielyan L, Schäfer R, von Ameln-Mayerhofer A, Bernhard F, Verleysdonk S, Buadze M, et al. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res. 2011;14:3–16.

Article  CAS  PubMed  Google Scholar 

Danielyan L, Beer-Hammer S, Stolzing A, Schäfer R, Siegel G, Fabian C, et al. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer’s and Parkinson’s disease. Cell Transplant. 2014;23 Suppl 1:S123–39.

Article  PubMed  Google Scholar 

Rhea EM, Logsdon AF, Banks WA, Erickson ME. Intranasal delivery: effects on the neuroimmune axes and treatment of neuroinflammation. Pharmaceutics. 2020;12:1120.

Article